These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20125101)

  • 1. Glucose levels and genetic variants across transcriptional pathways: interaction effects with BMI.
    Povel CM; Feskens EJ; Imholz S; Blaak EE; Boer JM; Dollé ME
    Int J Obes (Lond); 2010 May; 34(5):840-5. PubMed ID: 20125101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
    Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
    Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotypes of PPARGC1A are associated with glucose tolerance, body mass index and insulin sensitivity in offspring of patients with type 2 diabetes.
    Pihlajamäki J; Kinnunen M; Ruotsalainen E; Salmenniemi U; Vauhkonen I; Kuulasmaa T; Kainulainen S; Laakso M
    Diabetologia; 2005 Jul; 48(7):1331-4. PubMed ID: 15912394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility to pre diabetes mellitus and related association with obesity and physical fitness components in Mexican-Mestizos.
    Costa-Urrutia P; Abud C; Franco-Trecu V; Colistro V; Rodríguez-Arellano ME; Granados J; Seelaender M
    Prim Care Diabetes; 2018 Oct; 12(5):416-424. PubMed ID: 30041843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARGC1A sequence variation and cardiovascular risk-factor levels: a study of the main genetic effects and gene x environment interactions in children from the European Youth Heart Study.
    Brito EC; Vimaleswaran KS; Brage S; Andersen LB; Sardinha LB; Wareham NJ; Ekelund U; Loos RJ; Franks PW
    Diabetologia; 2009 Apr; 52(4):609-13. PubMed ID: 19183932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exonic peroxisome proliferator-activated receptor-γ coactivator-1α variation may mediate the resting energy expenditure through a potential regulatory role on important gene expression in this pathway.
    Mirzaei K; Hossein-nezhad A; Emamgholipour S; Ansar H; Khosrofar M; Tootee A; Alatab S
    J Nutrigenet Nutrigenomics; 2012; 5(2):59-71. PubMed ID: 22652814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of the estrogen-related receptor alpha and studies of association with obesity and type 2 diabetes.
    Larsen LH; Rose CS; Sparsø T; Overgaard J; Torekov SS; Grarup N; Jensen DP; Albrechtsen A; Andersen G; Ek J; Glümer C; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
    Int J Obes (Lond); 2007 Feb; 31(2):365-70. PubMed ID: 16755280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study.
    Lai CQ; Tucker KL; Parnell LD; Adiconis X; García-Bailo B; Griffith J; Meydani M; Ordovás JM
    Diabetes; 2008 Apr; 57(4):809-16. PubMed ID: 18162502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children.
    Lin YC; Chang PF; Chang MH; Ni YH
    Am J Clin Nutr; 2013 Feb; 97(2):326-31. PubMed ID: 23269818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.
    Franks PW; Christophi CA; Jablonski KA; Billings LK; Delahanty LM; Horton ES; Knowler WC; Florez JC;
    Diabetologia; 2014 Mar; 57(3):485-90. PubMed ID: 24317794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gly482Ser polymorphism in the peroxisome proliferator-activated receptor gamma coactivator-1alpha gene is associated with oxidative stress and abdominal obesity.
    Weng SW; Lin TK; Wang PW; Chen IY; Lee HC; Chen SD; Chuang YC; Liou CW
    Metabolism; 2010 Apr; 59(4):581-6. PubMed ID: 19913841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes.
    Barroso I; Luan J; Sandhu MS; Franks PW; Crowley V; Schafer AJ; O'Rahilly S; Wareham NJ
    Diabetologia; 2006 Mar; 49(3):501-5. PubMed ID: 16435105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study.
    van den Berg SW; Dollé ME; Imholz S; van der A DL; van 't Slot R; Wijmenga C; Verschuren WM; Strien C; Siezen CL; Hoebee B; Feskens EJ; Boer JM
    Int J Obes (Lond); 2009 Oct; 33(10):1143-52. PubMed ID: 19652658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha promoter polymorphisms are associated with early-onset type 2 diabetes mellitus in the Korean population.
    Kim JH; Shin HD; Park BL; Cho YM; Kim SY; Lee HK; Park KS
    Diabetologia; 2005 Jul; 48(7):1323-30. PubMed ID: 15937669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
    Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population.
    Zhu S; Liu Y; Wang X; Wu X; Zhu X; Li J; Ma J; Gu HF; Liu Y
    Diabetes Res Clin Pract; 2009 Dec; 86(3):168-72. PubMed ID: 19828207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.
    Stefan N; Thamer C; Staiger H; Machicao F; Machann J; Schick F; Venter C; Niess A; Laakso M; Fritsche A; Häring HU
    J Clin Endocrinol Metab; 2007 May; 92(5):1827-33. PubMed ID: 17327385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotype-based interaction of the PPARGC1A and UCP1 genes is associated with impaired fasting glucose or type 2 diabetes mellitus.
    Pei X; Liu L; Cai J; Wei W; Shen Y; Wang Y; Chen Y; Sun P; Imam MU; Ping Z; Fu X
    Medicine (Baltimore); 2017 Jun; 96(23):e6941. PubMed ID: 28591028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner.
    Brøns C; Jacobsen S; Nilsson E; Rönn T; Jensen CB; Storgaard H; Poulsen P; Groop L; Ling C; Astrup A; Vaag A
    J Clin Endocrinol Metab; 2010 Jun; 95(6):3048-56. PubMed ID: 20410232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level.
    Zhu L; Huang Q; Xie Z; Kang M; Ding H; Chen B; Chen Y; Liu C; Wang Y; Tang W
    Oncotarget; 2017 Jun; 8(23):37308-37320. PubMed ID: 28418876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.